Weight Loss · New York, NY
Tirzepatide (Mounjaro / Zepbound) in New York, NY
Tirzepatide (Mounjaro / Zepbound) is a once-weekly subcutaneous dual GIP/GLP-1 receptor agonist. In head-to-head trials it produced larger weight loss than semaglutide — averaging ~21% over 72 weeks at the maximum dose. FDA-approved for chronic weight management at BMI ≥30, or ≥27 with a comorbidity.
Typically used for:
Supporting significant weight loss and metabolic improvement in adults with overweight or obesity.
Benefits
What Tirzepatide (Mounjaro / Zepbound) can do for you.
Larger weight loss
Average 15–25% body-weight reduction at one year — larger than semaglutide in head-to-head trials.
Improved metabolic markers
Significant improvements in HbA1c, lipids, and liver enzymes accompany the weight loss.
Better appetite control
Many men report a meaningful reduction in food noise and improved satiety from the first few weeks.
How it works
From consult to follow-up.
Initial consultation
A board-certified physician reviews your symptoms, history, and goals. At many participating clinics the first visit is complimentary.
Baseline labs
Bloodwork tailored to the protocol. Results come back in days, not weeks. We don't prescribe before we have your numbers.
Personalized protocol
Your physician calibrates your dose based on your labs and your goals — not a template. Adjustments happen as your data evolves.
Ongoing follow-up
Recheck visits at six and twelve weeks, then quarterly. Real follow-up, structured into the plan.
- Duration
- Weekly self-injection, ~30 seconds
- Results timeline
- ~7% by week 12; peak loss between months 12–18
Designed around your schedule
Consults are short
Initial visits are typically 45–60 minutes. Many participating clinics waive the fee for new patients.
Telehealth follow-ups
Where state regulations allow, follow-up visits are conducted via telehealth — no extra drive time.
Medication shipped
Prescriptions ship directly from a 503B-licensed pharmacy. No standing in line.
Quarterly check-ins
Structured follow-up at six and twelve weeks, then quarterly. Real medicine, not a one-and-done.
New York clinics on the map
Where to get it
2 clinics and 2 providers offering tirzepatide (mounjaro / zepbound) in New York.
240 W. 37th Street, New York, NY, 10018
Provider offering this service
240 W. 37th Street, New York, NY, 10018
Provider offering this service
Patient reviews in New York
★★★★½4.7from 11 reviews
Doug M.
★★★★★New York, NY · Apr 2026
Honestly impressed by how methodical Dr. Dmitriy Schwarzburg, MD is. Started conservative, monitored, adjusted. That's how this should be done.
Source: Internal Sample · Verified
Jake C.
★★★★★New York, NY · Mar 2026
Did the IV series as part of a broader anti-aging plan. The provider was clear about what the evidence supports and what's still emerging. Appreciated the honesty.
Source: Internal Sample · Verified
Gus T.
★★★★☆New York, NY · Dec 2025
Booking was easy. Office is nice. The provider was thorough during the initial intake. Only knock is that appointments can run a little behind, but the care quality more than makes up for it.
Source: Internal Sample · Verified
Jake C.
★★★★★New York, NY · Nov 2025
Quick consult, fast labs, clear treatment plan. Jonathan Trager, MD answered every question without rushing. The patient portal makes follow-up easy.
Source: Internal Sample · Verified
Will F.
★★★★★New York, NY · Sep 2025
Took the time to actually answer my questions about side effects and long-term considerations. Didn't dodge anything. I respect that.
Source: Internal Sample · Verified
Frank L.
★★★★★New York, NY · May 2025
Front desk is responsive, scheduling is realistic, and the care plan is data-driven. Exactly what I was looking for after my last clinic kept dropping the ball on follow-ups.
Source: Internal Sample
Showing the 6 most recent of 11.
What sets us apart
The standard behind Tirzepatide (Mounjaro / Zepbound) in New York.
- Board-certified physicians.
- Every provider is licensed, NPI-verified, and credentialed by the GentsMed or Urosculpt certification board.
- A single clinical standard.
- The protocol meets the same criteria across every clinic in the network.
- Labs-driven, not guess-driven.
- No prescriptions without baseline labs. Dose calibration based on real numbers.
- Real follow-up.
- Structured check-ins built into every protocol. Not a one-visit Rx mill.
Get started
Talk to a New York physician about tirzepatide (mounjaro / zepbound).
Board-certified, vetted, and held to a single clinical standard.